Arrowpoint Investment Partners Singapore Pte. Ltd. bought a new stake in shares of Ambev S.A. (NYSE:ABEV - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,000,000 shares of the company's stock, valued at approximately $1,850,000. Ambev accounts for approximately 0.4% of Arrowpoint Investment Partners Singapore Pte. Ltd.'s portfolio, making the stock its 21st biggest holding.
A number of other large investors have also recently bought and sold shares of ABEV. CANADA LIFE ASSURANCE Co grew its position in shares of Ambev by 101.1% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 15,639,612 shares of the company's stock valued at $29,512,000 after buying an additional 7,862,672 shares during the last quarter. Private Management Group Inc. boosted its position in shares of Ambev by 8.1% during the 4th quarter. Private Management Group Inc. now owns 14,512,234 shares of the company's stock worth $26,848,000 after purchasing an additional 1,083,882 shares in the last quarter. Barclays PLC increased its holdings in shares of Ambev by 76.9% during the third quarter. Barclays PLC now owns 52,625 shares of the company's stock valued at $128,000 after acquiring an additional 22,880 shares in the last quarter. RWC Asset Management LLP increased its stake in Ambev by 4.4% during the 4th quarter. RWC Asset Management LLP now owns 13,063,556 shares of the company's stock valued at $24,168,000 after purchasing an additional 552,220 shares in the last quarter. Finally, Caprock Group LLC raised its holdings in shares of Ambev by 12.4% in the 4th quarter. Caprock Group LLC now owns 65,189 shares of the company's stock worth $128,000 after acquiring an additional 7,211 shares during the last quarter. 8.13% of the stock is currently owned by institutional investors and hedge funds.
Ambev Price Performance
Shares of ABEV traded up $0.02 during midday trading on Monday, reaching $2.53. The stock had a trading volume of 22,743,096 shares, compared to its average volume of 29,310,174. The company has a market capitalization of $39.79 billion, a price-to-earnings ratio of 14.03, a price-to-earnings-growth ratio of 5.80 and a beta of 0.80. The company has a current ratio of 1.20, a quick ratio of 0.89 and a debt-to-equity ratio of 0.02. Ambev S.A. has a 12-month low of $1.76 and a 12-month high of $2.64. The company's 50-day moving average is $2.40 and its 200 day moving average is $2.15.
Ambev (NYSE:ABEV - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.04 EPS for the quarter, hitting analysts' consensus estimates of $0.04. Ambev had a return on equity of 16.12% and a net margin of 17.02%. The business had revenue of $3.92 billion for the quarter, compared to analysts' expectations of $22.40 billion. On average, equities analysts predict that Ambev S.A. will post 0.18 EPS for the current fiscal year.
Ambev Cuts Dividend
The firm also recently disclosed a -- dividend, which will be paid on Thursday, July 17th. Shareholders of record on Monday, May 19th will be issued a $0.0219 dividend. This represents a yield of 5%. The ex-dividend date of this dividend is Monday, May 19th. Ambev's dividend payout ratio (DPR) is currently 68.75%.
Analysts Set New Price Targets
Several analysts have recently issued reports on the stock. Barclays upped their target price on shares of Ambev from $2.00 to $2.50 and gave the stock an "equal weight" rating in a research note on Monday, May 12th. Morgan Stanley lowered Ambev from an "equal weight" rating to an "underweight" rating in a report on Monday, April 7th. UBS Group lowered Ambev from a "buy" rating to a "neutral" rating in a report on Tuesday, April 22nd. Finally, Wall Street Zen started coverage on Ambev in a research note on Wednesday, April 23rd. They issued a "buy" rating for the company. One analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $2.70.
Check Out Our Latest Research Report on ABEV
About Ambev
(
Free Report)
Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.
Featured Articles
Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
